Business Context and Reporting Period
This Form 8-K Current Report from Zimmer Biomet Holdings, Inc. (ZBH) covers events occurring at the Annual Meeting of Shareholders held on May 14, 2021. The filing details the approval of amendments to equity incentive plans, director compensation plans, and corporate governance documents, as well as the results of shareholder votes on director elections and executive compensation.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The following material changes to corporate plans and governance were approved by shareholders and became effective:
- 2009 Stock Incentive Plan: Increased shares available for issuance by 5.8 million; extended the plan term to May 31, 2032; and eliminated obsolete provisions.
- Director Stock Plan: Replaced the $300,000 annual equity limit with a $700,000 annual total compensation limit (cash and equity); extended the term to December 31, 2032.
- Deferred Compensation Plan: Extended the term to December 31, 2032 and removed unused provisions.
- Charter and Bylaws: Amended the Restated Certificate of Incorporation to allow shareholders owning at least 15% of outstanding common stock to call a special meeting. Corresponding Bylaw amendments established procedural requirements for such requests.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The primary focus is on the successful ratification of governance proposals. Notably, the "Say on Pay" advisory vote (Proposal 3) received 158,537,741 votes in favor versus 12,353,884 against, indicating shareholder support for current executive compensation practices.
Investor Verification Checklist
- Verify the impact of the 5.8 million share increase on future dilution under the amended 2009 Stock Incentive Plan.
- Review the new $700,000 total compensation cap for non-employee directors to assess alignment with market standards.
- Confirm the procedural thresholds for the new 15% shareholder special meeting right in the amended Charter and Bylaws.
- Check the full text of the amended plans (Exhibits 10.1, 10.2, and 10.3) for specific vesting or eligibility changes not detailed in the summary.